Valuation Tiansheng Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. Other stock markets 2026-06-26			5-day change	1st Jan Change
4.520 ^CNY	-2.59%		-8.32%	-7.00%

05-08	Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement	MT
04-28	Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,507	1,660	1,679	1,631	1,444	1,545
Change	-	10.13%	1.15%	-2.84%	-11.5%	7.05%
Enterprise Value (EV) ¹	1,762	1,653	1,730	1,764	1,541	1,624
Change	-	-6.17%	4.65%	1.98%	-12.66%	5.42%
P/E	-3.07x	-24.5x	-18.5x	-17.5x	-16.5x	-27.9x
PBR	0.64x	0.73x	0.77x	0.78x	0.72x	0.79x
PEG	-	0.3x	-0.6x	-6.31x	2.71x	0.8x
Capitalization / Revenue	1.25x	2.25x	2.77x	2.82x	2.53x	3.01x
EV / Revenue	1.46x	2.24x	2.85x	3.05x	2.7x	3.16x
EV / EBITDA	-308x	68.3x	151x	97.8x	34.2x	25.3x
EV / EBIT	-14.4x	-22.8x	-18.5x	-20.5x	-25.4x	-29.4x
EV / FCF	9.44x	9.13x	-46.4x	-30.5x	26.6x	21.1x
FCF Yield	10.6%	11%	-2.16%	-3.28%	3.76%	4.74%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-1.543	-0.2132	-0.2848	-0.2927	-0.2749	-0.1743
Distribution rate	-	-	-	-	-	-
Net sales ¹	1,203	736.7	607	579.3	569.7	514.1
EBITDA ¹	-5.721	24.22	11.48	18.03	45.11	64.11
EBIT ¹	-122.6	-72.44	-93.65	-85.96	-60.56	-55.26
Net income ¹	-490.7	-67.81	-90.56	-93.07	-87.4	-55.42
Net Debt ¹	254.5	-6.895	50.92	132.9	97.19	78.93
Reference price ²	4.740	5.220	5.280	5.130	4.540	4.860
Nbr of stocks (in thousands)	318,000	318,000	318,000	318,000	318,000	318,000
Announcement Date	4/26/21	4/24/22	4/26/23	4/25/24	4/28/25	4/28/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TIANSHENG PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	211M
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	16.62x	6.50x	16.54x	2.43%	361.63B
Weighted average by Cap.	24.44x	7.95x	18.32x	1.97%